Sunday, February 16, 2025

CHAPTER 1. THE AMAZING REVOLUTION IN WHICH WE LIVE... ALMOST WITHOUT REALIZING IT YET

PART I.IF WE DON'T CHANGE THE WAY WE LOOK AT PARKINSON'S... WE WILL NEVER DEFEAT IT. 

CHAPTER 1. THE AMAZING REVOLUTION IN WHICH WE LIVE... ALMOST WITHOUT REALIZING IT YET. 

"There is nothing more powerful than an idea whose time has come". 
Victor Hugo 

"The crisis occurs when the old has not yet died and the new has not the new has not yet been born". 

Bertolt Brecht 

"Revolutions take place in dead ends". 

Bertolt Brecht 

Difficult to perceive and overwhelming on paper: from the union of the old and the new comes hope. The best of the East with its incredible Ayurvedic or Chinese herbal formulas to treat Parkinson's together with the best of the West through brain scans, the growing role of various forms of physical exercise, of vitamins B1, B2, D3 and B12, as well as the combination of acetyl carnitine and alpha lipoic acid to restore the mitochondria. We live at a time when everything seems covered in dark clouds and there is great darkness, but we also see rays of sunshine breaking through those same depressing clouds. We are on the edge of the precipice, but there is an accumulation of very important research and information, and changes that lead to hope where there seems to be no reason. It is there, but it is not easy to see it. It takes a lot of coincidences and causalities to pull back the veils. At least that is what has happened to me over the last 30 years. 
Brave neurologists have left us videos that have the virtue of breaking through the thick wall of current prejudices with a very powerful efficacy. This is not the simplification of every problem out of a fit of arrogance or ignorance, but the attentive compilation of what neurologists ahead of their time or contrary to the dominant discourse say, only in that sense they would be "dissidents" within the authentic orthodoxy, that of the search for the truth, such as Birkmayer, Shults, Coimbra, Perlmutter, Costantini, Fancellu, etc. 
I have learned more about what is definitive in unravelling the mystery of Parkinson's as a historian and digital journalist than as a son and caregiver. The testimonies, clues and evidence are abundant. Hundreds, perhaps thousands. Books, studies, articles, news... But the thick jungle does not let us see those trees. One of the paradoxes of the world of Parkinson's, not of the disease or its possible treatments, is that a real revolution is taking place and that it is so difficult to see because it is found in hundreds of studies that are not very accessible to the public and because it is almost buried by thousands and thousands of other studies and various news items, which in my opinion lead to greater complexity and, therefore, to increasing confusion (subtypes of Parkinson's, division between brain and enteric initiates, the role of alphasynuclein, etc.). What we are interested in "here and now" is what we already know works: antioxidants, anti-inflammatories, mitochondrial activators, reduction of the neurotoxic homocysteine, physical exercise... Be it drugs, supplements, herbal medicines, Indian and Chinese herbal formulas, medicinal mushrooms, therapies, etc. Like a swarm attacking Parkinson's until it becomes weaker and weaker... until it is expelled if possible or as far as possible. 

1. Evidence for this revolution. 

In this book very radical statements are made which seem to be based only on the author's good wishes, but I can assure you that this is not the case. After the death of Oliver Sacks (the famous doctor in the movie "Awakenings"), there are two really famous neurologists left in the world: one orthodox, Stanley Fahn, who treated the boxer Muhammad Ali and the actor Michael J Fox; and one heterodox, David Perlmutter, the famous author of the most impressive videos in Parkinson's History showing the "miraculous" recovery of several patients almost unable to move and speak thanks to the use of intravenous glutathione (and strong doses of the main B vitamins that were part of the preparatory protocol, which would explain why glutathione has not been so effective in later studies). We should not forget the healing potency of Costantini's B1, Coimbra's B2, Birkmayer's NADH/B3, Christine and McCarter's B12, etc.). We are talking about neurologists. I insist on this "detail". We are talking about another way of looking at Medicine and Neurology. This is part of the revolution... But not only David Perlmutter, but also the Brazilian neurology professor and neurologist Coimbra, the Italian neurologists Costantini and Fancellu, the Argentinean Villafañe with the nicotine patches until they closed his practice at the Henri Mondor Hospital in Paris, and a very long etcetera. Wise men who have passed away, such as the great Walter Birkmayer, other younger ones who move on the frontiers of what we know, such as Borah, Aoyama, Mischley, Espay, Villafañe, Monti... It is a mystery how a real revolution can have developed in the last decade on the role of scientific studies and how almost nothing has reached the majority of patients and their families or the clinical practice in the daily private and public consultations of neurologists. Some examples are: Alberts (2011), forced physical exercise on a bicycle (in tandem with a healthy person), produces a physical benefit of 35-40 %, like a dose of levodopa; Suzuki (2013), vitamin D3 can slow the disease (at 1200 IU daily for one year, UPDRS scale); Phillipson (2013), with a combination of supplements and regular medication one patient got his symptoms under control; Schaffner (2019), vitamin B12 is able to silence (epigenetically) the main gene of so-called familial or genetic Parkinson's: LRRK2. Monti (2019), with the use of oral and parenteral NAC (N-acetylcysteine), a precursor of vital and scarce glutathione in Parkinson's patients, increases dopamine receptors and significantly improves motor symptoms; Fullard (2020), vitamin D3 affects and ameliorates almost everything in Parkinson's disease. In 20 minutes on the beach, the body synthesises between 10,000 and 25,000 IU of vitamin D3. 

2. The revolution in the world of Parkinson's. 

I write this simply as my father's son and carer until his death in 2012. Since then as a searcher and disseminator of everything I "rediscover" in books and study databases, thanks to Google and Pubmed. The first alarm signal was when I found a specialised manual on dyskinesias in Parkinson's and it did not even mention pyridoxine or vitamin B6, despite the studies by Sandyk 1990 or Lerner 2007 and 2015, etc. An article by Chilean neurologists Juri and Chaa in 2006 put me on the track. I don't even mention nicotine or melatonin. You can see that this is orthodoxy, but orthodoxy that has been forgotten or marginalised. But it was also happening to me on the CAM (complementary and alternative medicine) side. One of the most famous books on food and health did not even mention Parkinson's (or Alzheimer's either). And when my father was still alive, we desperately consulted an expert in alternative medicines (it would be 2010) and he confessed to us with great honesty that he knew very little, that there was hardly anything. He recommended alpha lipoic acid and a type of spinal massage. When one visits many sites on the internet on both sides, confusion increases, because strange therapies abound, very difficult to carry out and generally very expensive. Not a word about homocysteine, vitamin C (essential for tyrosine, carnitine, to enter the brain as its oxidised form and to be brought back to life (as an antioxidant) by glutathione or NADH, to recycle glutathione, to activate B9 against homocysteine, etc. ), NAC as a way to raise glutathione (which plummets to a catastrophic 2 % in the most advanced stage of the disease), milk thistle to help the overburdened liver in those sick from medication, etc. 

3. The end of Parkinson's as we have seen it so far. 

And the revolution we have been living through for some years now is reflected in very hopeful changes, some of which have already been mentioned: - adult neurogenesis is possible (between Ramón y Cajal's Nobel publication in 1928 and Erikson's study in 1998, adult neurogenesis was thought to be impossible). - GABA could be as important as dopamine in Parkinson's disease (Sabatini 2012, Sulzer 2015). The*** same enzyme that transforms dopa into dopamine transforms tryptophan into serotonin or GABA. - Epigenetics comes to rescue us from the fear of genes, from the heavy burden of genetics. Genes do not have the last word. Vitamin B12 controls the main gene for hereditary Parkinson's, LRRK2 (Schaffner 2019). Vitamin D acts on more than 2000 genes known so far, magnesium is so important in gene regulation that Piovesan speaks of a "magnesome". We should not forget the pioneering twin studies by Tanner and Maher, both in 2002... - the neurons of the "sustantina nigra pars compacta" (SNpc) that we thought were dead, could be largely dormant or "deactivated" (Heo 2020); - dangerous homocysteine, elevated in Parkinson's patients and more so in those taking levodopa, could trigger alpha-synuclein aberration (Enomoto 2019); - a different vision is advanced with the use of nutraceuticals to "starve" Parkinson's (Lama 2020); We already know enough about the disease (although much needs to be clarified and more studies are needed) and about treatments (a synthetic levodopa could be used, adding the compounds that make Mucuna pruriens infinitely superior; or Mucuna with carbidopa or benserazide, together with new MAO inhibitors of plant origin; studies on nutrition, vitamins such as the forgotten B1, B2 and B3, which seem to be marginalised). What holds the Parkinson's world back is the way the Parkinson's world itself has developed in recent decades. Its dimensions, the economic interests at stake (patents, profits, careers) are factors that can distort the free action of research towards curing the disease. Most of the time unconsciously, dragged along by the mainstream. 
The challenge is not easy.

Monday, March 20, 2023

Ecological therapy for Parkinson's disease 2023: (Medication, late and little), by neurologist Rafael Gonzalez Maldonado

 


The prestigious Spanish neurologist Rafael González Maldonado has published a new book that I recommend to everyone: 

  "Ecological therapy for Parkinson's disease 2023: (Medication, late and little)".

I liked the pages I have been able to read on Amazon a lot: brave and full of treasures. I have already bought it on paper and I am looking forward to reading and studying it. 

 My father used to tell me very often about any doubt: "I'll see what Maldonado says." His copy of "The Strange Case of Dr. Parkinson" is so worn and annotated... There is no greater praise possible from a reader towards a book. 

Help me to publicize it and to let all the sick and family members know it.

 https://www.amazon.es/Ecological-therapy-Parkinsons-disease-Medication/dp/B0BTZXHXRG

Friday, March 10, 2023

Closer to checkmate to Parkinson's (1): what Dr. Phillipson says.


This year 2023 marks the 10th anniversary of the publication of a writing by Dr. Phillipson and an interview about its content. 

 


 

Oliver T. Phillipson is a Harvard scientist. A sage who accumulates decades of experience in the study of aging, mitochondria and Parkinson's disease. And he has a dream that I share. And I think many of us who participate in these forums as well, full of interest and hope:


SLOW DOWN AND REVERSE 

THE PARKINSONIAN DEGENERATIVE PROCESS.

One of the ways to better understand what Parkinson's means today (end of the twentieth century and beginning of the twenty-first: Parkinson's diseases, orthodox and heterodox treatments, world of Parkinson's), it seems to me the chronological study of the work of the most notable researchers in some important aspect of Parkinson's disease. Dr. Phillipson stands out for the study of aging and mitochondrial damage. We have few sources: actually four. His 2013 study, an interview and two more studies:


2013. Inhibition of Aging in Parkinson’s Disease: A Case Study.
2014. Management of the aging risk factor for Parkinson's disease.
2017. Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management.


In 2013, as mentioned below, the effectiveness of the five supplements used synergistically is proven: alpha lipoic acid, acetyl-l-carnitine, coenzyme Q10, melatonin and vitamin E.

I think it's important to mention Zhang and colleagues' 2010 study on the combined use of R-alpha-lipoic acid and acetyl-L-carnitine. Not only for its effectiveness, but for the fact that together they greatly increase their potency and require lower doses. (Zhang et al. 2010. Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease. J Cell Mol Med.)

As well as the fact that he claims that coenzyme Q10 is very important, but not enough to defeat this hundred-headed hydra.

In 2014, the combination of alpha lipoic acid, acetyl-l-carnitine, coenzyme Q10, and melatonin.

In 2017 he mentions R-lipoic acid, acetyl-l-carnitine, ubiquinol, melatonin (or receptor agonists), and vitamin D3.

Like many other great neuroscientists, both in the field of Neurology and in other scientific specialties, they have come to focus on the mitochondria, the cellular energy factory.

Just as Dr. William Osler ("father" of modern medicine) nearly 100 years ago considered Parkinson's to be an accelerated aging of the brain, Phillipson now focuses on the "normal" aging process and its similarities and differences with Parkinson's.


Two excerpts from the interview in which the author reveals safe clues about Parkinson's in general:

"… many of the disease markers for PD are also found in normal aging though in less severe form. This includes recent findings of under expressed epigenetic signaling factors which control energy metabolism and antioxidant control. In some respects, therefore, but not all, PD can be viewed as a severe aging process. Putting right these energy deficits resulting from gene and mitochondrial dysfunction seen in both normal aging and PD, might therefore be an effective way to reduce the impact of disease progression. Results from research into normal aging have yielded nutritional methods by which this might be achieved."


"…this combination of supplements (derived from research into normal aging), is known to improve energy metabolism, mitochondrial function and reduce oxidative stresses which are known to be damaging to key elements of metabolic pathways important for energy production. Perhaps more importantly they also improve the epigenetic expression of factors which control the de novo biosynthesis of mitochondria and maintain their structural integrity."

 

I believe that Dr. Phillipson will leave a very important mark on this silent revolution that we live in and on the road to the definitive cure of this disease.


---

In the book I published in 2022 in English, "The cure for Parkinson's", I mention him in several pages:

392

"Oliver Phillipson's 2013 article teaches us valuable lessons. He used coenzyme Q10, but realised that it alone cannot cope with the overwhelming power of Parkinson's disease, but in combination or synergy with others. Together they were able to beat the disease."


313-315

"3. Phillipson's protocol.

The figure of Oliver T. Phillipson seems to me to be very important in the world of Parkinson's as we will see in the future.

He has a very interesting "Letter to the Editor" published in 2013. For what he says and for the coincidences with other protocols and studies by neurologists such as Perlmutter.

It refers to a patient with Parkinson's disease. He was taking conventional treatment and Phillipson was adding supplements with little success over 11 years until he got a set of them in the right doses and acting synergistically alongside the allopathic treatment.

Usual medication:
carbidopa/levodopa (750 mg/d),
pramipexole (300 mg/d),
entacapone (600 mg/d),
amitriptyline (25 mg/d).

Supplements:
melatonin (0.2-0.8 mg at night),
a-lipoic acid (200 mg/d),
acetyl-l-carnitine (250 mg/d),
CoQ (maintenance dose 200-400 mg/d)
and vitamin E (400 IU/d).

I find the conclusions reached by Professor Phillipson very interesting. The possibility of acting on Parkinson's disease by revitalising the mitochondria and slowing down ageing.

Previous experience of using Coenzyme Q10 alone in early Parkinson's disease suggests that it may result in a limited slowing of progression, but, nevertheless, progression continued and there was no improvement in motor function and no reversal of Parkinson's disease symptoms.

In contrast, in the present case, Parkinson's disease symptoms appear to be resolved and progression was halted with the combination of melatonin, a-lipoic acid plus acetyl-l-carnitine and Coenzyme Q10.

For example, Coenzyme Q10 alone could not stop it, but in combination with others, it did its job effectively.

The supplements were selected to support the function of ageing mitochondria by maintaining cellular energy resources and resisting oxidative and nitrosative stress."


(Jesus Marquez Rivera, "Parkinson's here and now").

Wednesday, October 5, 2022

CHAPTER 7. CASES OF POSSIBLE HEALING AND SELF-HEALING.





CHAPTER 7.
CASES OF POSSIBLE HEALING AND SELF-HEALING.

(from my latest book: "The Cure for Parkinson's. Do We Already Know What It Takes to Checkmate the Disease?").


"Tell a sick person that he has no hope (or let him find out through his
family) and the will to live will be paralysed.
Show him a way out, pull him away from fear and hysteria,
 give him even a little hope and the will to live will be stimulated.
It will become a powerful ally in battle".

Harry A. Hoxsey, who set up cancer clinics in Texas
and other places in the United States during the 1930s and 1940s (until the
30s and 40s of the 20th century (until they were banned and closed).



The question that interests me in the first place is not whether the cases are true or not. What interests me more is the possibility that they were, to break through our negative "beliefs" about a disease that we consider incurable.

As we have seen in the previous chapter, on the borders of the Parkinsonian "bubble" and beyond, it is possible to find doctors, neurologists and other neuroscientists who make extraordinary claims that bring us hope.

"The future is not in the genes".
Tim Spector, geneticist and Head of Genetics at King's College.



1. A wonderful mistake of ours: the case of a woman called "Fatima".


This story, told by the famous Spanish neurologist Dr. Rafael González Maldonado in his book "The strange case of Dr. Parkinson" (pp. 198-199), shocked my father and me so much that it became part of our conversations from then on (1999):


"In my first year of residency I saw many patients but none I remember like Fatima. She was fifty-five years old although she looked like an old woman on the verge of extinction. She was, like the vast majority of our patients, a housewife who had only known the limits of a territory that she now found empty, like the sack of her illusions. Once again, a story of depression, sexual apathy, rigid education and, now, faithful widowhood. It would have gone unnoticed in my memory if we had not met, three years later, on a flight to Isla Margarita. It was she who recognised me, and my surprise was enormous when I realised that that old parkinsonian woman was now a healthy and vital woman, with a beautiful maturity on the verge of exploding. I had problems with my hotel booking and she invited me to her home, where I discovered the secret of her healing. Shortly after leaving my hospital, Fatima had met by chance a Venezuelan of her age, a painter and globetrotter who had a small estate on Isla Margarita; they shared literary interests and that was the excuse for long conversations at dinners that followed one after the other; he revived in her an old vitality and even returned to writing stories as when she was a child. Fatima forgot her western doctors, her friends in Spain and accompanied him. Today they plant vegetables, fruit trees and fragrant flowers in their gardens, and sunbathe on the wet grass. They take a siesta on a bed suspended between trees and make love, between sobs and laughter, in different and perfumed settings. Their dinners are prolonged between candles, good cigarettes and the odd joint, and the long gatherings only give way at dawn. Fatima no longer has Parkinson's (or it's as if she didn't)".

Although it is a fiction written on the basis of several real clinical cases, we took it for a long time as real (and it only turned out to be a lucky mistake, a confusion of great importance for us, because it inspired us a lot). It motivated us in a way we could not even suspect. Slowly, too slowly, that reading began to change our view of Parkinson's. My father used to refer to it as the "Parkinson's book". My father used to refer to it often. Had it not been in this book that we valued so highly from a respected and admired neurologist, we would have taken it as a joke at the time, such was our ignorance and so many were our prejudices. Even so, the surprise was enormous, disconcerting. We could not quite believe it. We thought that, in any case, it would be something unique, exceptional. Later, as the years went by, we accumulated more experiences and information, and we heard about similar cases. So the suspicion grew that something very important was missing. Our limited, conventional view of Parkinson's was insufficient.


2. The strange case of John Gillies.

In May 2008, an Australian Parkinson's sufferer named John Gillies was suffering from severe episodes of "freezing" in his ability to move. He had been diagnosed for four years. He was treated with antibiotics because his gastroenterologist, Dr. Thomas Borody, Director of the Centre for Digestive Diseases in Australia, suspected that his severe constipation might be due to an infection in his colon ("Clostridium difficile"). After treatment, the patient felt that his parkinsonian symptoms had disappeared. Two neurologists examined him and found no trace of the disease.

3. A formidable woman, Annetta Freeman.

The case of this brave and determined Californian woman came to us late for my father. Although I knew about it, I dismissed it as an anecdotal case, of no importance to us. Only after my father's death, and after several years of reading and many less prejudices, was I able to understand the value of her testimony, which survives only thanks to Steven Fowkes and the interviews of the 1990s.

4. The extraordinary work of Robert Rodgers.

Robert Rodgers is one of the pillars of the English-speaking Parkinsonian community. Although in the next chapter we will show some of the much he has contributed to Parkinson's patients and families, it seems necessary to mention his work "Pioneers of Recovery". He has books, such as the interview with John Coleman, and hundreds of radio programmes, some of them with people who claim to have recovered from Parkinson's disease.

5. The cases discussed by Phillipson (2013) and Smart (2016).

The case mentioned by Oliver T. Phillipson in his 2013 article is of particular value because it involves an eleven-year follow-up. (See chapter 22, section 3). What no single supplement could do alone, he achieved with a combination of them together with his antiparkinsonian medication.

Neuroscientist Karishma Smart and colleagues published in 2016. A 78-year-old man, with 16 years of diagnosed disease, reportedly experienced remission of his Parkinson's disease. Diagnosed by a neurologist, he responded well to levodopa and underwent a positive SPECT DaT scan as confirmation of the Parkinson's diagnosis, which appears to rule out diagnostic error. The practice of daily deep prayer/meditation over years would be the most characteristic and possible cause. Pagnoni in 2007 reported that regular meditation can counteract damage to the striatum and dopaminergic depletion.

6. Parkinsonisms that can be cured.

Parkinsonisms (secondary or caused by a known cause) can and usually can be cured.

There are certain nutrient deficiencies that can produce parkinsonian symptoms: tremor (magnesium), fatigue (vitamin C), loss of smell (zinc), etc. It is therefore not surprising that certain parkinsonisms have disappeared with the use of vitamins such as vitamin C (Nobile 2013, Quiroga 2014) or B12 (Priolisi 1959, Soysal 2018).

Immunotherapy to treat melanoma, although the symptoms returned after the therapy ended (Shprecher 2014).

Vascular Parkinsonism (Lobo 2013).



7. Can oriental medicines "cure" Parkinson's?

Recently, I have been able to learn about and understand cases of possible cures thanks to Indian Ayurvedic medicine and Traditional Chinese Medicine.



1) Observational clinical study with Ayurvedic medicine (Pathel 2018).

Pathel mentions cases who, after several months of treatment in two phases (purifying and symptomatic), moved from stage 3 to stage 1 on the Hoehn and Yahr scale. Measurements with the UPDRS scale were also significant. 16 patients reduced their symptoms from stage 3 to 1.5. Another 10 patients reduced their symptoms from 3 to 1.


2) Case report (Binth 2018).

A 58-year-old patient, diagnosed with Parkinson's 15 years earlier. He was taking 700 mg levodopa per day. After comprehensive Ayurvedic treatment (massages, oils, etc.) and given the improvement experienced, he was able to reduce the dose of levodopa to 100 mg per day. The improvement in his daily life was measured with various scales. Between 30 and 50% with the Schwab and England (activities of daily living).

3) 10 cases treated with Chinese medicine.

10 patients were reportedly cured of idiopathic Parkinson's disease in not very advanced stages with the use of the Chinese herbal formula.

Wang Weifang, published in the "Journal of Brain and Neurology" ten cases of possible (and controversial) cures over the last three decades, using Xifengzhizhan pills and Xifenzhizhan capsules.

These results were presented at the 7th International Conference on Brain Disorders and Therapeutics 2020, which took place in Prague, Czech Republic.

The main components of Xifengzhichan Pills are: Shudi, cornel meat, medlar, chrysanthemum, Ligustrum lucidum, Gastrodia elata, uncaria, polygonatum, asparagus, etc. The main components of Xifengzhizhan capsules are: white peony root, ejiao, turtle shell, cistanche deserticola, natural ground, radix scrophulariae, radix bidentata, etc.

Xifengzhichan Pills, 9 grams each time, three times a day; Xifengzhichan Capsules, 6 capsules each time, three times a day. Oral administration.

In other studies, it is referred to as "Xifeng Dingchan Pill" (XFDCP). For example, in:

Zhang (2013). Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson's disease: study protocol of a multicenter, open-label, randomized active-controlled trial.

Testing its efficacy alone and with Madopar.


8. Some neurologists and B vitamins.

Some cases of Coimbra and vitamin B2.

In the study published in 2002 by Dr. Cicero Coimbra, neurologist and professor of Neurology, several patients who took doses of vitamin B2 for 6 months, would have recovered 100% of their capacities. Brazilian television showed recordings of some of these patients who had already recovered.

Some cases of Costantini and vitamin B1.

In the studies published by the Italian neurologist Antonio Costantini in 2011 and 2015, as well as in the videos published on various websites, before and during the treatment, a spectacular improvement can be observed in many patients.

The spectacular videos of the first Perlmutter.

Although the substance was glutathione intravenously (slowly as with the serum bags), the fact is that the patients were subjected to a protocol of vitamins of the B group: 50 mg of B1, B2, B3, etc.

When Hauser and Perlmutter did their 2009 study, the results were disappointing. Perhaps because the patients did not receive these vitamins, which are so effective in treating Parkinson's and so important for glutathione synthesis and mitochondrial function.

We must remember that Sechi and his team achieved in 1996 a significant improvement in patients treated with intravenous glutathione. Their study inspired the work of Dr. Perlmutter. 

Tuesday, September 27, 2022

New book in English: The Cure for Parkinson's. Do We Already Know What It Takes to Checkmate the Disease?

 

The Cure for Parkinnson's. 

Do We Already Know What It Takes to Checkmate the Disease?

 


On Amazon.com 

 

Jesús Márquez Rivera was born and lives in La Línea de la Concepción, a Spanish city bordering Gibraltar. He studied Philosophy and Letters, specializing in Contemporary History in Granada (Spain), between 1990 and 1995. Then he has done radio and digital journalism on issues related to health, longevity and Parkinson's above all.

After 28 years attentive to the world of Parkinson's, first as a caregiver for his father (1994-2012) and then as a researcher and disseminator of "transformative" information through the project "Parkinson's here and now" in Spanish and English (2012-2022), Jesús Márquez Rivera has dared to write a book with a title as unexpected as it is surprising: "The Cure for Parkinson's. Do We Already Know What It Takes to Checkmate the Disease?".

Years ago it would have seemed crazy or a deception such a proposal. In all these years there has been the necessary change in the author to dare to face this exciting and honest challenge: he sincerely believes that it is possible to defeat Parkinson's, opening the mind to Nature and the East. And looking closely at these 50-60 years of recent history of Parkinson's (the era of Levodopa). Ancient and recent treasures, from Karobath in 1971 to Monti in 2019...


NOTE. I'm still looking for a patron (mecenas) or editor who will allow me to have the time/quiet/means to devote myself completely to this. I keep in mind several more books, brochures, videos, podcasts... I just need enough money.
And most importantly: topics ideas and intuitions to find and rediscover the essentials: denervation and vitamin B12, locus coruleus and magnesium, high doses of vitamin D3 recommended by neurologists and other doctors, etc. Contact: jesusmarquezrivera at yahoo dot es

Wednesday, March 23, 2022

The end of Parkinson's as we know it today. From the Levodopa era to the transformative information era.




1. History and Time.

As a vocational and professional historian, I have contemplated the world of Parkinson's for many years. The changes over time in the way the disease is viewed, the possible treatments and everything that makes up the world of Parkinson's (multinationals, neurologists, associations, foundations, governments, investors, journals, etc.), provide us with much valuable information.

Comparisons are essential for change. They are only unpleasant when the intentions behind them are unpleasant.

In these years we are at a crossroads. We have two main options:

1. We can leave the levadopa era (1970-2022) behind, keeping what is worthwhile and move into another way of looking at the disease and its treatments. We cannot continue without introducing Mucuna (with or without carbidopa); homocysteine reduction with vitamins B2, B6, B9 and B12; the use of sublingual vitamin B12; substances that raise glutathione as well as providing innumerable benefits (alpha lipoic acid, vitamin C, selenium, turmeric, etc.); high doses of vitamin D3 (5000-10000 IU per day) and even calcitriol, etc.


2. Or continue in the loop, in the labyrinth, going round in circles waiting for the treatment that will change everything. I know what I am talking about because my father and I were lost for more than a decade, like mice on a wheel in the maze. The volume of information produced today is a hundred times greater than it was 20 years ago, but the goal is receding. The complexity of research is now impossible to harness and increasingly resembles the Maelstrom, the giant sea whirlpool that drags everything to the bottom.

2. Neurology can take different paths.

We are not talking about alternative issues or issues far removed from science. The studies, proposals and therapies of doctors Hinz, Wahls, Hoffer, Perlmutter, Coimbra, Costantini, Birkmayer, Ahlskog, Fahn (1992), Shults (2002), Suzuki (2013), Espay (2019), etc., remain unheeded.

We are ending the month of March 2022 and what I see reminds me of what I experienced 30 years ago with my father. "Old wine in a new bottle". Or "The same dog with a different collar", is a frequent saying in my mother tongue, Spanish.

3. The Internet, a double-edged sword.

The Internet, search engines, databases, forums, have changed everything. It is true that they are a double-edged sword. Alongside invaluable information there are oceans of rubbish and unimportant information.

We search and search. Thanks to all this volume of information we can go astray or stumble upon vitamin D3, sublingual vitamin B12, a multivitamin of methylated B vitamins, green tea polyphenols, turmeric, Mediterranean diet, mucuna, melatonin, etc.


4. Re-learning to read.

"People don't know how much time and effort it takes to learn to read. It has taken me eighty years to achieve it, and I still can't say whether I have succeeded."
Goethe

Looking back, I remember how many times I "read" books and articles without understanding what their authors were saying. How the years went by and I did not understand what they were shouting at us from those pioneering pages... How many prejudices, ignorance, separated us from the paths that lead to hope based on realities.



5. Not a step back.

I am finishing the translation of "The Cure of Parkinson's" into English, I still can't find a patron or publisher who will allow me to devote myself to research and disseminate full time, etc. Intuition (shortcut to knowledge) tells me that there is still a lot to bring to light, to gather and summarise, to explain in an understandable way what is essential for the majority of patients and their families who do not have the free time or the drive to search and search. Or that their mother tongue does not allow them to access 99% of the information, which is nowadays only available in English.

As I receive more and more messages from readers who are changing their view of Parkinson's in a positive way thanks to the book in Spanish (actually to the fact that I have gathered so many treasures from others in it), I have to come to the conclusion that (almost) nobody cares about the future of sufferers and their families. Except ourselves, of course.

And we are in danger of being almost erased from the internet, from memory, as happened to Annetta Freeman and her exceptional protocol in the 1990s, which brings us to Jay Kimball with his product Liquid Deprenyl Citrate (LDC), imprisoned and banned respectively, etc.

But we must not forget that it would put an end to the current and future profits of the giant "actors" in this drama. Nor can we ignore that the colossal "Parkinson's world" is already seeking its own survival as if it were a living organism.

We must make the best of the Laboratory, of Nature and of the treasures of the East.

If we do not do it ourselves, it is likely to remain undone. When you come to this conviction, everything changes.

Sunday, February 20, 2022

Parkinson's could be otherwise (2): towards cure.


 


Officially, Parkinson's is still incurable in Western medicine.

Cases of possible cure or reversal of symptoms occur in very strong or highly motivated people (Robert Rodgers has collected numerous cases since 2004. His mother had Parkinson's). And in Hindu and Chinese medicine, it is considered a difficult disease to treat, but not incurable.

The same is said about Alzheimer's or Multiple Sclerosis, but there are doctors/neurologists who have called it into question: Seignalet, Bradesen, Newport, Swank, Wahls...

Many neurologists speak of a syndrome and some propose different therapies (Coimbra, Costantini, Birkmayer, Perlmutter). The cause would be multiple (and maybe impossible to know exactly). It must therefore be treated as something that is multifactorial, due to multiple deficiencies (Hinz speaks of 29)...

The Hindus and the Chinese created multi-modal and multi-phase treatments centuries ago. Their products and therapies (massages, acupuncture, movements) treat all possible routes of damage (detoxification, antioxidants, anti-inflammatory, liver protection, good nutrition, etc.).

The cause may persist (high stress sensitivity to stress, genetic aspects, etc.) or not (high stress stage already overcome, poor nutrition, etc.). Outside of current Western medicine, there are no incurable diseases. Difficult to treat/cure, yes, but not impossible. But we already know many antidotes: anti-stress magnesium, epigenetic measures, Mediterranean diet and phytotherapy, etc.

One can follow the orthodox Western path, the Eastern ones, a mixture of both (there are very interesting studies on madopar together with Chinese formulas), or the external ways of highly motivated patients (Freeman, Pepper, Coleman, Shifke). Whatever the choice, and with the supervision of a specialist, I would continue with a new lifestyle: Mediterranean diet or similar, green tea (with ginger and turmeric with a little black peppercorns), lion's mane mushroom, a daily salad, vitamin D3 supplement (together with magnesium and brewer's yeast), omega 3 fish pearls, physical exercise, acupuncture, etc.

AYURVEDA.

See planetayurveda.com. Parkinson's Formulas.

https://www.planetayurveda.com/library/parkinsonism/

- Observational clinical study with Ayurvedic medicine (Pathel 2018):

Pathel mentions cases who, after several months of treatment in two phases (purifying and symptomatic), moved from stage 3 to stage 1 on the Hoehn and Yahr scale. Measurements with the UPDRS scale were also significant. 16 patients reduced their symptoms from stage 3 to 1.5. Another 10 patients went from stage 3 to 1.

TRADITIONAL CHINESE MEDICINE.

And this other amazing one for TCM:

http://www.itmonline.org/arts/parkinsons.htm

Some formulas backed by studies, either claiming healing results/significant improvements or anti-parkinson effects of their components: oxidation, inflammation, glutamate, parkinsonizing toxins, etc.

Zichan powder,

Yigansan formula,

Xifengzhizhan pills and capsules,

Zeng-xiao An-shen Zhi-chan 2 or ZAZ2,

Zishenpingchan granules (Ye 2021).

Liuwei dihuang or Liu Wei Di Huang Wan (Tseng 2014, Rehmannia Six Formula).

- 10 cases treated with Chinese medicine:

10 patients reportedly cured of idiopathic Parkinson's in not very advanced stages with use of Chinese herbal formula

Wang Weifang, published in the Journal of Brain and Neurology ten cases of possible (and controversial) cures over the last three decades, using Xifengzhizhan pills and Xifenzhizhan capsules.

These results were presented at the 7th International Conference on Brain Disorders and Therapeutics 2020, which took place in Prague, Czech Republic.

The main components of Xifengzhichan Pills are: Shudi, cornel meat, medlar, chrysanthemum, Ligustrum lucidum, Gastrodia elata, uncaria, polygonatum, asparagus, etc. The main components of Xifengzhizhan capsules are: white peony root, ejiao, turtle shell, cistanche deserticola, natural ground, radix scrophulariae, radix bidentata, etc.

Xifengzhichan Pills, 9 grams each time, three times a day; Xifengzhichan Capsules, 6 capsules each time, three times a day. Oral administration.

In other studies, it is referred to as "Xifeng Dingchan Pill" (XFDCP). For example, in:

Zhang (2013). Evaluation on the efficacy and safety of Chinese herbal medication Xifeng Dingchan Pill in treating Parkinson's disease: study protocol of a multicenter, open-label, randomized active-controlled trial.

Testing its efficacy alone and with Madopar.

---

The guidance of a doctor and, if possible, a doctor trained in both Western and Oriental medicine is always recommended.